nuvoteQ
nuvoteQ is a Pretoria-based clinical trial technology company building FDA/EMA-compliant low-code SaaS platforms (Kronus CTMS, Nukleus EDC, SafetyBase pharmacovigilance) for pharmaceutical companies, CROs, biotech firms, and African research sites across 40+ countries.
- Company typePrivate
- Founded2015
- HeadquartersPretoria, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What nuvoteQ does
nuvoteQ (Pty) Ltd is a Pretoria, South Africa-headquartered clinical trial technology company founded in 2015 that builds cloud-based, low-code/no-code software platforms for regulated life sciences workflows. Its three commercial products are Kronus (a FDA-validated Clinical Trial Management System), Nukleus (an Electronic Data Capture platform functioning as eSource, EDC, or Patient Support Program), and SafetyBase (a web-based pharmacovigilance platform for adverse event reporting), all compliant with FDA 21 CFR Part 11, EMA Annexure 11, ICH GCP, HIPAA, and GDPR. The company also operates three ecosystem platforms — CTC.Africa (clinical trial community for African sites), the EDCTP Alumni Network (researcher collaboration for sub-Saharan Africa), and HealthBeat (patient engagement for healthcare providers such as Intercare Group) — built on the same underlying technology architecture.
nuvoteQ serves pharmaceutical companies, contract research organizations, biotech firms, academic research sites, and healthcare providers, with named customers including Pfizer, MSD, Takeda, Bayer, Genentech/Biocon, Aspen Pharmacare, Premier Research, and ImmunoVel. The company positions itself as the only African-headquartered vendor with dual FDA and EMA software compliance, and claims to have supported one of the world's largest COVID-19 vaccine trials across 50+ hospitals. Its technology is differentiated by front-end configurability that reduces configuration costs and time by up to 80%, deep integrations with medical coding libraries (MedDRA, WHO-DD ICD-10), VigiBase, and Azure AD, and a global footprint spanning 40+ countries across 5 continents.
The company operates an enterprise field-sales GTM with demo-led engagement, recurring SaaS subscriptions on the core Kronus/Nukleus/SafetyBase products, and project-funded deployments on the ecosystem platforms. Revenue is undisclosed; the only known capital event is a $150,000 grant from the Jack Ma Foundation's Africa Business Heroes competition in 2026. The leadership team consists of co-founder and CEO Adriaan Kruger, CPO Marina Lazaridis, CTO Charl Bachuis, COO Nicolene du Plessis, and CDO Corneile Liebenberg, with the company remaining privately held and founder-controlled.
nuvoteQ firmographics
Firmographics- Name
- nuvoteQ
- Legal name
- nuvoteQ (Pty) Ltd
- Website
- https://nuvoteq.io
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- nuvoteQ is a Pretoria-based clinical trial technology company building FDA/EMA-compliant low-code SaaS platforms (Kronus CTMS, Nukleus EDC, SafetyBase pharmacovigilance) for pharmaceutical companies, CROs, biotech firms, and African research sites across 40+ countries.
- Ownership category
- akta.pro rank
nuvoteQ industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Management Systems (CTMS) (HLACAOAD)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
Keywords
Where nuvoteQ is headquartered
LocationHeadquarters
- HQ city
- Pretoria
- HQ country
- South Africa
- HQ region
- Africa
Offices1 record
Markets served
nuvoteQ business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Platform Subscriptions: nuvoteQ provides cloud-based software platforms (Kronus, Nukleus, SafetyBase) to pharmaceutical companies, CROs, and research organizations. The platforms are configured to customer needs and delivered as subscription-based SaaS solutions with regulatory compliance built in.
- Professional Services and Implementation: The company provides customized digital infrastructure development, implementation, and execution services as part of their customer engagement process. This includes cross-functional team deployment of specialists to configure and implement solutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
nuvoteQ product offering
Product offeringCore offering
nuvoteQ develops and sells cloud-based, FDA-validated SaaS platforms for clinical trial management, electronic data capture, and pharmacovigilance targeting pharmaceutical companies, CROs, and research organizations. Its core products are Kronus (CTMS), Nukleus (EDC), and SafetyBase (pharmacovigilance), built with low-code/no-code configurability and compliance with FDA 21 CFR Part 11, EMA Annexure 11, ICH GCP, HIPAA, and GDPR. The company also operates project platforms such as CTC.Africa, the EDCTP Alumni Network, and HealthBeat for patient engagement.
Product overview
nuvoteQ provides a platform-plus-modules architecture with three core software products for clinical and pharmaceutical research: Kronus (Clinical Trial Management System), Nukleus (Electronic Data Capture), and SafetyBase (Pharmacovigilance). These platforms are designed with front-end configurability, allowing customers to configure solutions without coding. Kronus provides end-to-end trial management with FDA validation, Nukleus handles electronic data capture and eSource capabilities, and SafetyBase manages adverse event reporting and regulatory compliance. Additionally, nuvoteQ operates project-specific platforms including CTC.Africa for clinical trial investment in Africa, EDCTP Alumni Network for researcher collaboration, and HealthBeat for patient management. The platform architecture enables interoperability with a focus on cost-effectiveness, flexibility, and accessibility while maintaining compliance with FDA CFR-11, EMA Annexure 11, and ICH GCP standards.
Differentiator
Problem solved
Functional benefit
Brands
- Kronus: Clinical Trial Management System (CTMS) offering FDA-validated solution with worksheets, documents, calendars, contacts, schedules, payments, milestones, and compliance features.
- Nukleus
- Safetybase
- HealthBeat
- CTC.Africa
- EDCTP Alumni Network
Products and services
- Kronus Kronus is nuvoteQ's FDA-validated Clinical Trial Management System (CTMS) offering end-to-end support across worksheets, documents, calendars, contacts, schedules, payments, milestones, master data management, document management with eTMF, dashboard analytics, electronic consent, patient management with ePRO, learning management, and study startup tracking. It targets pharmaceutical companies, CROs, and research organizations running regulated clinical trials.
- Nukleus Nukleus is nuvoteQ's hybrid, secure web-based Electronic Data Capture (EDC) platform functioning as eSource, EDC, or Patient Support Program. It eliminates data transcription through low-code/no-code configuration including role-based access, edit checks, logic, calculations, workflows, and notifications, and includes a visit scheduler wizard, integrated MedDRA/WHO-DD/ICD-10 medical coding, interactive web response services, electronic patient reported outcomes (ePRO), and a local lab module. It is targeted at sponsors, CROs, and research sites running clinical trials.
- SafetyBase SafetyBase is nuvoteQ's web-based pharmacovigilance platform accessible via modern browsers on any device. It facilitates real-time collection and submission of adverse event, product complaint, and medical information data with MedDRA and WHO-DD coding, customizable dashboards, alerts and notifications, audit trails, VigiBase integration, and compliance with 21 CFR Part 11, EMA Annexure 11, HIPAA, GDPR, and SOC-3. It targets pharmaceutical companies and CROs needing safety reporting and risk management.
- CTC.Africa CTC.Africa is nuvoteQ's Clinical Trial Community platform showcasing African clinical trialists and research sites, providing transparent access to country-specific regulatory and ethics procedures. It offers comprehensive profiling, digital feasibility requests, discussion forums, and registry integrations for global sponsors seeking African research sites.
- EDCTP Alumni Network EDCTP Alumni Network is a virtual community platform for EDCTP Fellows providing research profiles, grant trends analysis, and key performance indicators for tracking fellow production and retention in sub-Saharan Africa. It supports networking and collaboration among research fellows affiliated with African institutions.
- HealthBeat HealthBeat is nuvoteQ's patient-centric online platform providing patient profile management, online bookings for GP and dental visits, on-demand online GP consultations, mental health services, real-time payment processing, AI-powered symptom checking, and intelligent appointment management. It is currently deployed for healthcare provider groups such as Intercare Group in South Africa.
Quantifiable outcome
- Reduces configuration costs and time by up to 80%
- +3 more outcomes
Companies that use nuvoteQ
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles4 records
nuvoteQ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature6 records
nuvoteQ partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- EDCTP (European & Developing Countries Clinical Trials Partnership)coreEDCTP partners with nuvoteQ on the CTC.Africa platform to increase clinical trial investments in Africa and the EDCTP Alumni Network to foster networking among research fellows. EDCTP supports four Regional Networks of Excellence in Africa.
- Impact Global Health (IHME)minorPartnership provides R&D funding data for the CTC.Africa platform analytics, showing disease prevalence and funding received by African institutions.
- Science for Africa FoundationminorListed as a project partner working to improve visibility and attract investment to African clinical trials through mapping of trial centers.
- Global HealthminorListed as a project partner supporting clinical research initiatives in Africa.
- Intercare GroupcorenuvoteQ developed the HealthBeat patient engagement platform specifically for Intercare Group, a South African healthcare provider. The platform provides online bookings, telehealth consultations, and mental health services for Intercare patients.
- SAHPRA (South African Health Products Regulatory Authority)corenuvoteQ established a foundation working with African regulators like SAHPRA to reduce medicine registration backlogs using AI, with a goal to shift Africa's share of clinical research from 3% to 5%.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
nuvoteQ competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva Vault CTMS and Vault EDC are enterprise-grade clinical trial management and electronic data capture platforms serving the same pharma, biotech, and CRO buyer base as nuvoteQ. Both compete on configurability, FDA/EMA compliance, and global multi-study deployments.
- Medidata Solutions (Dassault Systèmes): Medidata's Rave EDC, CTMS, eCOA, and RTSM are the dominant enterprise standard in clinical trial data capture and management. nuvoteQ's Nukleus and Kronus compete most directly with Medidata's stack for new and mid-tier sponsors and CROs.
- Clario: Clario delivers eCOA, EDC, medical imaging, and trial endpoint solutions to pharma and CRO sponsors. Overlap with nuvoteQ is strongest in EDC and clinical data capture for regulated, multi-country trials.
- Oracle Clinical One: Oracle's Clinical One platform unifies CTMS, EDC, and randomization into a single cloud platform, mirroring nuvoteQ's CTMS/EDC/PV product triad. Both target regulated pharma and CRO customers seeking integrated, compliant clinical trial technology.
- ArisGlobal: ArisGlobal's LifeSphere Safety and clinical platforms provide pharmacovigilance, EDC, and CTMS for pharma companies — directly comparable to nuvoteQ's SafetyBase (PV), Nukleus (EDC), and Kronus (CTMS) offerings.
Broad incumbents
- IQVIA: IQVIA combines a global CRO with technology platforms (including EDC and clinical data management). Its scale and CRO relationship overlap with nuvoteQ's CRO customer segment make it a broad incumbent competitor.
Emerging players
- Medrio: Medrio provides cloud EDC, ePRO, and eConsent for clinical trials, emphasizing rapid build timelines and mid-market sponsor/CRO customers — directly comparable positioning to nuvoteQ's Nukleus and Kronus.
- OpenClinica: OpenClinica offers open-source and cloud EDC and ePRO solutions for clinical trials, including a focus on academic, government, and emerging-market sponsors. Comparable to nuvoteQ on EDC functionality and accessibility to non-enterprise customers.
- Castor EDC: Castor is a cloud-based EDC platform known for rapid study deployment and configurability, serving academic and commercial sponsors globally. Comparable to nuvoteQ's Nukleus on ease-of-configuration and on-time study startup.
Regional players
- RealTime Software Solutions: RealTime provides CTMS, eDOCS, and eSource for clinical research sites, with strong adoption across North American research sites. Comparable to nuvoteQ's Kronus CTMS for site-facing trial management workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
nuvoteQ social profiles
Digital presencenuvoteQ compliance and trust
Trust signalCompliance7 records
nuvoteQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
nuvoteQ leadership team
Management profileNumber of profiles
Profiles6 records
nuvoteQ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
nuvoteQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about nuvoteQ
What does nuvoteQ do?
nuvoteQ develops and sells cloud-based, FDA-validated SaaS platforms for clinical trial management, electronic data capture, and pharmacovigilance targeting pharmaceutical companies, CROs, and research organizations. Its core products are Kronus (CTMS), Nukleus (EDC), and SafetyBase (pharmacovigilance), built with low-code/no-code configurability and compliance with FDA 21 CFR Part 11, EMA Annexure 11, ICH GCP, HIPAA, and GDPR. The company also operates project platforms such as CTC.Africa, the EDCTP Alumni Network, and HealthBeat for patient engagement.
Is nuvoteQ a public or private company?
nuvoteQ is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was nuvoteQ founded?
nuvoteQ was founded in 2015. It employs 11 to 50 people.
Where is nuvoteQ based?
nuvoteQ is headquartered in Pretoria, South Africa, in the Africa region.
How does nuvoteQ make money?
Two revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are professional Services and Implementation.
Who are nuvoteQ's main competitors?
Direct peers on record are Veeva Systems, Medidata Solutions (Dassault Systèmes), Clario, Oracle Clinical One and ArisGlobal. IQVIA is listed as a broad incumbent. Emerging players are Medrio, OpenClinica and Castor EDC. RealTime Software Solutions is listed as a regional player.
Does nuvoteQ have an API?
No public API is recorded for nuvoteQ.
What industry is nuvoteQ in?
nuvoteQ's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLACAOAD, Clinical Trial Management Systems (CTMS), with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 51821 and its SIC code is 7372.